Please assess the completion status of the following clinical trial:

Trial Title: Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Had given birth within the last 24 hours~* Ability and willingness to give informed consent for HIV testing and enrollment into the study~* Willing to receive HIV results~* HIV infected~* Planning to deliver or had given birth at the study clinics~* Willing to come back for follow-up visits for 2 years postnatally~* Resident of Blantyre city or its suburbs~Exclusion Criteria:~* HIV negative~* Women with discordant HIV results~* Women who indicate that they will not breastfeed at time of delivery~* Inability or unwillingness to follow any of the inclusion requirements~* Newborn with life-threatening condition~* Women who previously enrolled in this study and have a second pregnancy cannot reenroll

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 54 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): Single dose NVP + ZDV daily for the first week.
- C (Type: EXPERIMENTAL): Arm A plus NVP + ZDV daily to age 14 weeks.
- B (Type: EXPERIMENTAL): Arm A plus oral NVP daily to age 14 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).